Impact of hyperglycemia on the results of percutaneous coronary interventions in patients with acute ST-segment elevation myocardial infarction

Terapevticheskii Arkhiv

Volumn 89, Issue 9, 2017, Pages 25-29

  Bessonov, I S ^a   Kuznetsov, V A ^a   Potolinskaya, Yu V ^a   Zyrianov, I P ^a   Sapozhnikov, S S ^a  

^a Russian Academy of Sciences   (Russian Federation)

Author keywords

Hyperglycemia.; Primary percutaneous coronary interventions; ST segment elevation myocardial infarction

Indexed keywords

AGED; ANALYSIS; BLOOD; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MALE; MIDDLE AGED; MORTALITY; NO REFLOW PHENOMENON; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; RESTENOSIS; RETROSPECTIVE STUDY; RISK FACTOR; RUSSIAN FEDERATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; CORONARY RESTENOSIS; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MORTALITY; NO-REFLOW PHENOMENON; ODDS RATIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES; RISK FACTORS; RUSSIA; ST ELEVATION MYOCARDIAL INFARCTION;

EID: 85031673724     PISSN: 00403660     EISSN: 23095342     Source Type: Journal    
DOI: 10.17116/terarkh201789925-29     Document Type: Article

References (16)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. The Lancet. 2003;361:13-20. https://doi.org/10.1016/s0140-6736(03)12113-7
2. Kuznetsov V, Yaroslavskaya E, Pushkarev G, Zyryanov I, Bessonov I, Gorbatenko E, Nyamtsu A. Interrelation of percutaneous coronary interventions for acute forms of coronary heart disease and mortality parameters in Tyumen region inhabitants. Russian journal of cardiology. 2014;6(110):42-46. (In Russ.)]. https://doi.org/10.15829/1560-4071-2014-6-42-46
3. Planer D, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Xu K, et al. Impact of hyperglycemia in patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention: The HORIZONS-AMI trial. Int J Cardiol 2013;167(6):2572-2579. https://doi.org/10.1016/j.ijcard.2012.06.054
4. Naber CK, Mehta RH, Junger C, Zeymer U, Wienbergen H, Sabin GV, et al. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry). The American Journal of Cardiology. 2009;103(5):583-587. https://doi.org/10.1016/j.amjcard.2008.11.005
5. Zhang J, Zhou Y, Cao S, Yang Q, Yang S, Nie B. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coronary Artery Disease. 2013;24(5):352-356 https://doi.org/10.1097/mca.0b013e328361a942
6. Deckers JW, van Domburg RT, Akkerhuis M, Nauta ST. Relation of Admission Glucose Levels, Short-and Long-Term (20-Year) Mortality After Acute Myocardial Infarction. The American Journal of Cardiology. 2013;112(9):1306-1310. https://doi.org/10.1016/j.amjcard.2013.06.007
7. Koracevic GP. Proposal of a New Approach to Study and Categorize Stress Hyperglycemia in Acute Myocardial Infarction. The Journal of emergency medicine. 2016;51(1):31-36 https://doi.org/10.1016/j.jemermed.2015.03.047
8. De Mulder M, Cornel J, Ploeg T, Boersma E, Umans VA. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. American Heart Journal. 2010;160(3):412-419. https://doi.org/10.1016/j.ahj.2010.06.047
9. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2008;117(12):1610-1619. https://doi.org/10.1161/circulationaha.107.188629
10. Stegenga ME, Crabben SN, Levi M, de Vos AF, Tanck MW, Sauerwein HP, et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes. 2006;55(6):1807-1812. https://doi.org/10.2337/db05-1543
11. Jensen CJ, Eberle HC, Nassenstein K, Schlosser T, Farazandeh M, Naber CK, et al. Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI. Clinical Research in Cardiology. 2011;100(8):649-659. https://doi.org/10.1007/s00392-011-0290-7
12. Ishihara M. Acute hyperglycemia in patients with acute myocardial infarction. Circulation Journal. 2012;76(3):563-571. https://doi.org/10.1253/circj.cj-11-1376
13. Bessonov I, Kuznetsov V, Zyryanov I, et al. Primary percutaneous interventions into the coronary arteries in patients with diabetes mellitus. Therapeutic archives. 2016; 88(8):35-39. (In Russ.)]. Doi: 10.17116/terarkh201688835-39
14. Gruppetta M, Calleja N, Fava S. Long-Term Survival After Acute Myocardial Infarction and Relation to Type 2 Diabetes and Other Risk Factors. Clinical cardiology. 2010;33:424-429. https://doi.org/10.1002/clc.20776
15. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. 2012;33(20):2569-2619. https://doi.org/10.1016/j.rec.2012.10.010
16. American Diabetes Association. Standards of Medical Care in Diabetes - 2010. Diabetes Care. 2010;33(Suppl.1):S11-S61. https://doi.org/10.2337/dc10-s011